Clinical Trial Update: Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic [Phase 2]

View source ↗

Summary

Phase 2 trial update for a new centrally acting analgesic in diabetic polyneuropathy completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy

Drugs mentioned

• centrally acting analgesic

Snippet

Sponsor: Tris Pharma, Inc. | Conditions: Diabetic Polyneuropathy | Phase 2 | Status: COMPLETED